Our economic performance can be measured through our investment in innovative research and development, where we are looking for new and better treatments for:
- Fibrotic Diseases
- Exploratory Areas
It can be measured through our history of successful efforts and partnerships to develop and deliver important new medicines to people who need them. Finally, our performance can be measured through our efforts to help expand people’s access to quality medicines and health care, through worldwide public/private partnerships. Examples include the following areas of focus of The Bristol-Myers Squibb Foundation: lung cancer in the United States; HIV and comorbid diseases such as cervical and breast cancers, tuberculosis and mental health disorders in sub-Saharan Africa; hepatitis B and C in Asia; veterans’ mental health and well-being in the United States; and type 2 diabetes in the United States, China and India; as well as our patient assistance programs.
For more detailed information about our financial goals, our performance and additional relevant information, see our company’s Investors site, our Annual Report and our Foundation Bristol-Myers Squibb Report.